Literature DB >> 24881566

Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).

Steven M Sparks1, Grace Chen2, Jon L Collins3, Dana Danger3, Steven T Dock3, Channa Jayawickreme2, Stephen Jenkinson4, Christopher Laudeman4, M Anthony Leesnitzer2, Xi Liang3, Patrick Maloney4, David C McCoy4, David Moncol2, Vincent Rash2, Thomas Rimele2, Padmaja Vulimiri2, James M Way3, Sean Ross3.   

Abstract

The exploration of a diarylsulfonamide series of free fatty acid receptor 4 (FFA4/GPR120) agonists is described. This work led to the identification of selective FFA4 agonist 8 (GSK137647A) and selective FFA4 antagonist 39. The in vitro profile of compounds 8 and 39 is presented herein.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FFA4; Free fatty acid receptor 4; Free fatty acid receptor 4 agonist; Free fatty acid receptor 4 antagonist; GPR120

Mesh:

Substances:

Year:  2014        PMID: 24881566     DOI: 10.1016/j.bmcl.2014.05.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  27 in total

1.  Linoleic acid induces migration and invasion through FFAR4- and PI3K-/Akt-dependent pathway in MDA-MB-231 breast cancer cells.

Authors:  Nathalia Serna-Marquez; Ricardo Diaz-Aragon; Emmanuel Reyes-Uribe; Pedro Cortes-Reynosa; Eduardo Perez Salazar
Journal:  Med Oncol       Date:  2017-04-29       Impact factor: 3.064

2.  Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in Raw 264.7 macrophages.

Authors:  Ameneh Cheshmehkani; Ilya S Senatorov; Jyothi Dhuguru; Ola Ghoneim; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2017-09-21       Impact factor: 5.858

3.  Functional expression of the free fatty acids receptor-1 and -4 (FFA1/GPR40 and FFA4/GPR120) in bovine endometrial cells.

Authors:  Pamela Valenzuela; Stefanie Teuber; Carolina Manosalva; Pablo Alarcón; Carlos D Figueroa; Marcelo Ratto; Rafael A Burgos; Maria A Hidalgo
Journal:  Vet Res Commun       Date:  2019-06-11       Impact factor: 2.459

4.  Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 Diabetes.

Authors:  Xuqing Zhang; Chaozhong Cai; Zhihua Sui; Mark Macielag; Yuanping Wang; Wen Yan; Arthur Suckow; Hong Hua; Austin Bell; Peter Haug; Wilma Clapper; Celia Jenkinson; Joseph Gunnet; James Leonard; William V Murray
Journal:  ACS Med Chem Lett       Date:  2017-07-27       Impact factor: 4.345

Review 5.  Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease.

Authors:  Timothy D O'Connell; Katherine A Murphy; Naixin Zhang; Sara J Puccini; Chastity L Healy; Brian A Harsch; Michael J Zhang; Gregory C Shearer
Journal:  Physiology (Bethesda)       Date:  2022-08-09

Review 6.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

7.  GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.

Authors:  Gabriele Carullo; Sarah Mazzotta; Margarita Vega-Holm; Fernando Iglesias-Guerra; José Manuel Vega-Pérez; Francesca Aiello; Antonella Brizzi
Journal:  J Med Chem       Date:  2021-04-10       Impact factor: 7.446

Review 8.  Anti-Atherosclerotic Potential of Free Fatty Acid Receptor 4 (FFAR4).

Authors:  Anna Kiepura; Kamila Stachyra; Rafał Olszanecki
Journal:  Biomedicines       Date:  2021-04-24

9.  GPR120 signaling controls amyloid-β degrading activity of matrix metalloproteinases.

Authors:  Kazunori Kikuchi; Takuya Tatebe; Yuki Sudo; Miyabishara Yokoyama; Kiwami Kidana; Yung Wen Chiu; Sho Takatori; Makoto Arita; Yukiko Hori; Taisuke Tomita
Journal:  J Neurosci       Date:  2021-06-04       Impact factor: 6.167

Review 10.  Long Chain Fatty Acids as Modulators of Immune Cells Function: Contribution of FFA1 and FFA4 Receptors.

Authors:  Maria A Hidalgo; Maria D Carretta; Rafael A Burgos
Journal:  Front Physiol       Date:  2021-07-01       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.